Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
- PMID: 24943594
- PMCID: PMC4204770
- DOI: 10.1093/hmg/ddu311
Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
Abstract
Candidate variant association studies have been largely unsuccessful in identifying common breast cancer susceptibility variants, although most studies have been underpowered to detect associations of a realistic magnitude. We assessed 41 common non-synonymous single-nucleotide polymorphisms (nsSNPs) for which evidence of association with breast cancer risk had been previously reported. Case-control data were combined from 38 studies of white European women (46 450 cases and 42 600 controls) and analyzed using unconditional logistic regression. Strong evidence of association was observed for three nsSNPs: ATXN7-K264R at 3p21 [rs1053338, per allele OR = 1.07, 95% confidence interval (CI) = 1.04-1.10, P = 2.9 × 10(-6)], AKAP9-M463I at 7q21 (rs6964587, OR = 1.05, 95% CI = 1.03-1.07, P = 1.7 × 10(-6)) and NEK10-L513S at 3p24 (rs10510592, OR = 1.10, 95% CI = 1.07-1.12, P = 5.1 × 10(-17)). The first two associations reached genome-wide statistical significance in a combined analysis of available data, including independent data from nine genome-wide association studies (GWASs): for ATXN7-K264R, OR = 1.07 (95% CI = 1.05-1.10, P = 1.0 × 10(-8)); for AKAP9-M463I, OR = 1.05 (95% CI = 1.04-1.07, P = 2.0 × 10(-10)). Further analysis of other common variants in these two regions suggested that intronic SNPs nearby are more strongly associated with disease risk. We have thus identified a novel susceptibility locus at 3p21, and confirmed previous suggestive evidence that rs6964587 at 7q21 is associated with risk. The third locus, rs10510592, is located in an established breast cancer susceptibility region; the association was substantially attenuated after adjustment for the known GWAS hit. Thus, each of the associated nsSNPs is likely to be a marker for another, non-coding, variant causally related to breast cancer risk. Further fine-mapping and functional studies are required to identify the underlying risk-modifying variants and the genes through which they act.
© The Author 2014. Published by Oxford University Press.
Figures


References
-
- Breast Cancer Association Consortium. Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J. Natl. Cancer Inst. 2006;98:1382–1396. - PubMed
-
- Bojesen S.E., Pooley K.A., Johnatty S.E., Beesley J., Michailidou K., Tyrer J.P., Edwards S.L., Pickett H.A., Shen H.C., Smart C.E., et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat. Genet. 2013;45:371–384. - PMC - PubMed
-
- Cox A., Dunning A.M., Garcia-Closas M., Balasubramanian S., Reed M.W., Pooley K.A., Scollen S., Baynes C., Ponder B.A., Chanock S., et al. A common coding variant in CASP8 is associated with breast cancer risk. Nat. Genet. 2007;39:352–358. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- CA54281/CA/NCI NIH HHS/United States
- CA116201/CA/NCI NIH HHS/United States
- CA128978/CA/NCI NIH HHS/United States
- C1287/A10710/CRUK_/Cancer Research UK/United Kingdom
- R01CA148667/CA/NCI NIH HHS/United States
- 1U19 CA148065/CA/NCI NIH HHS/United States
- R01 CA128978/CA/NCI NIH HHS/United States
- CA098758/CA/NCI NIH HHS/United States
- R01CA64277/CA/NCI NIH HHS/United States
- UM1 CA164920/CA/NCI NIH HHS/United States
- P30 CA68485/CA/NCI NIH HHS/United States
- R37 CA070867/CA/NCI NIH HHS/United States
- 16565/CRUK_/Cancer Research UK/United Kingdom
- R01 CA092447/CA/NCI NIH HHS/United States
- 11022/CRUK_/Cancer Research UK/United Kingdom
- CA122340/CA/NCI NIH HHS/United States
- 1U19 CA148537/CA/NCI NIH HHS/United States
- R01 CA100374/CA/NCI NIH HHS/United States
- CA63464/CA/NCI NIH HHS/United States
- C490/A10124/CRUK_/Cancer Research UK/United Kingdom
- U01 CA116167/CA/NCI NIH HHS/United States
- R01CA100374/CA/NCI NIH HHS/United States
- R01 CA064277/CA/NCI NIH HHS/United States
- U19 CA148537/CA/NCI NIH HHS/United States
- R01 CA148667/CA/NCI NIH HHS/United States
- R37CA70867/CA/NCI NIH HHS/United States
- P50 CA116201/CA/NCI NIH HHS/United States
- N01CN25403/CN/NCI NIH HHS/United States
- C1287/A12014/CRUK_/Cancer Research UK/United Kingdom
- R01 CA063464/CA/NCI NIH HHS/United States
- 090532/WT_/Wellcome Trust/United Kingdom
- P30 CA015083/CA/NCI NIH HHS/United States
- 16563/CRUK_/Cancer Research UK/United Kingdom
- CRN-87521/CAPMC/ CIHR/Canada
- U01 CA063464/CA/NCI NIH HHS/United States
- R01 CA077398/CA/NCI NIH HHS/United States
- R01 CA054281/CA/NCI NIH HHS/United States
- R01 CA132839/CA/NCI NIH HHS/United States
- P30 CA068485/CA/NCI NIH HHS/United States
- R01 CA77398/CA/NCI NIH HHS/United States
- 1U19 CA148112/CA/NCI NIH HHS/United States
- 090532/Z/09/Z/WT_/Wellcome Trust/United Kingdom
- U19 CA148112/CA/NCI NIH HHS/United States
- U01 CA098758/CA/NCI NIH HHS/United States
- N01 CN025403/CA/NCI NIH HHS/United States
- CA132839/CA/NCI NIH HHS/United States
- U19 CA148065/CA/NCI NIH HHS/United States
- R01 CA122340/CA/NCI NIH HHS/United States
- UM1 CA182910/CA/NCI NIH HHS/United States
- 10118/CRUK_/Cancer Research UK/United Kingdom
- C1287/A10118/CRUK_/Cancer Research UK/United Kingdom
- 001/WHO_/World Health Organization/International
- R37 CA054281/CA/NCI NIH HHS/United States
- 16561/CRUK_/Cancer Research UK/United Kingdom
- 10124/CRUK_/Cancer Research UK/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases